| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.
|
N Engl J Med
|
2014
|
5.08
|
|
2
|
VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study.
|
J Clin Oncol
|
2009
|
1.54
|
|
3
|
[Appearing of bone marrow derived stem cells in healthy and regenerating colonic epithelium].
|
Orv Hetil
|
2009
|
1.40
|
|
4
|
Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
|
Thromb Haemost
|
2008
|
1.38
|
|
5
|
Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis.
|
Pathol Oncol Res
|
2007
|
1.37
|
|
6
|
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
|
J Clin Oncol
|
2013
|
1.07
|
|
7
|
Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia.
|
Leuk Res
|
2011
|
0.98
|
|
8
|
A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.
|
Am J Hematol
|
2015
|
0.92
|
|
9
|
Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.
|
Adv Ther
|
2014
|
0.83
|
|
10
|
Lymphoid aggregates may contribute to the migration and epithelial commitment of bone marrow-derived cells in colonic mucosa.
|
J Clin Pathol
|
2011
|
0.83
|
|
11
|
Serum beta2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults.
|
Clin Chem Lab Med
|
2009
|
0.82
|
|
12
|
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
|
Acta Haematol
|
2011
|
0.80
|
|
13
|
Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
|
Acta Biomed
|
2006
|
0.77
|
|
14
|
NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma.
|
Br J Haematol
|
2014
|
0.77
|
|
15
|
Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma.
|
World J Surg Oncol
|
2014
|
0.75
|
|
16
|
Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
|
Acta Haematol
|
2010
|
0.75
|
|
17
|
[Stem cell therapy in cardiovascular diseases].
|
Orv Hetil
|
2005
|
0.75
|
|
18
|
[Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection].
|
Orv Hetil
|
2007
|
0.75
|
|
19
|
Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.
|
Med Oncol
|
2011
|
0.75
|
|
20
|
Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
|
Am J Dermatopathol
|
2010
|
0.75
|
|
21
|
[Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
|
Orv Hetil
|
2011
|
0.75
|
|
22
|
Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma.
|
Int J Hematol
|
2011
|
0.75
|
|
23
|
Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation.
|
Eur J Haematol
|
2013
|
0.75
|
|
24
|
[Experiences with the first, Hungarian autologous bone marrow cell transplantation in acute myocardial infarction].
|
Orv Hetil
|
2006
|
0.75
|